Invesco Ltd. Prometheus Biosciences, Inc. Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$103.46 - $126.29 $7.93 Million - $9.67 Million	76,603 Added 27.05%	359,749 $38.6 Million
Q4 2022 Feb 13, 2023	SELL	$36.06 - $117.21 $194,940 - $633,637	-5,406 Reduced 1.87%	283,146 $31.1 Million
Q3 2022 Nov 14, 2022	BUY	$28.17 - $59.01 $7.71 Million - $16.2 Million	273,784 Added 1853.9%	288,552 $17 Million
Q2 2022 Aug 15, 2022	BUY	$22.39 - $38.94 $92,627 - $161,094	4,137 Added 38.91%	14,768 $417,000
Q1 2022 May 16, 2022	SELL	$30.13 - $50.0 $1.54 Million - $2.56 Million	-51,219 Reduced 82.81%	10,631 $402,000
Q4 2021 Feb 14, 2022	BUY	$22.28 - $39.54 $1.38 Million - $2.45 Million	61,850 New	61,850 $2.45 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.